BRN AM | Classifying aging as a disease could speed FDA drug approvals | Amy L. Baker, Life Sciences & Technology Attorney, Rimon, PC | Tunein: broadcastretirementnetwork.com or your favorite streaming / podcast / smarttv platform | Subscribe for daily curated news in lifestyle, finance, tech, wellness & more.

BRN AM | Classifying aging as a disease could speed FDA drug approvals | Amy L. Baker, Life Sciences &amp; Technology Attorney, Rimon, PC | Tunein: broadcastretirementnetwork.com or your favorite streaming / podcast / smarttv platform | Subscribe for daily curated news in lifestyle, finance, tech, wellness &amp; more.

BRN AM | Classifying aging as a disease could speed FDA drug approvals

The Broadcast Retirement Network (BRN) is the first lifestyle media platform focused on helping Americans achieve financial independence and to make retirement and savings culturally relevant.  The content is informative and engages the viewer. Most importantly - No agendas, no sales pitches, no product pushes.

News

Business News

The Broadcast Retirement Network (BRN) is the first lifestyle media platform focused on helping Americans achieve financial independence and to make retirement and savings culturally relevant. The content is informative and engages the viewer. Most importantly - No agendas, no sales pitches, no product pushes.

Share BRN AM | Classifying aging as a disease could speed FDA drug approvals

Sign up to save your podcasts

BRN AM | Classifying aging as a disease could speed FDA drug approvals

BRN AM | Classifying aging as a disease could speed FDA drug approvals